Evidence map›Paper›PMID 25769928›Full record

Trial reportJournal of immunology (Baltimore, Md. : 1950)2015

Perturbed T cell IL-7 receptor signaling in chronic Chagas disease.

M Cecilia Albareda, Damián Perez-Mazliah, M Ailén Natale, Melisa Castro-Eiro, María G Alvarez, Rodolfo Viotti, Graciela Bertocchi, Bruno Lococo, Rick L Tarleton, Susana A Laucella

Open access · bronzeAbstract readClinical TrialComparative StudyMulticenter Study
In one paragraph

Trial report in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Understanding CD8Trends in parasitology · 2019
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

M Cecilia AlbaredaInstituto Nacional de Parasitología Dr. M. Fatala Chaben, Buenos Aires 1063, Argentina; Hospital Interzonal General de Agudos Eva Perón, 1650 San Martin, Buenos Aires, Argentina; and.
Damián Perez-MazliahInstituto Nacional de Parasitología Dr. M. Fatala Chaben, Buenos Aires 1063, Argentina;
M Ailén NataleInstituto Nacional de Parasitología Dr. M. Fatala Chaben, Buenos Aires 1063, Argentina;
Melisa Castro-EiroInstituto Nacional de Parasitología Dr. M. Fatala Chaben, Buenos Aires 1063, Argentina;
María G AlvarezHospital Interzonal General de Agudos Eva Perón, 1650 San Martin, Buenos Aires, Argentina; and.
Rodolfo ViottiHospital Interzonal General de Agudos Eva Perón, 1650 San Martin, Buenos Aires, Argentina; and.
Graciela BertocchiHospital Interzonal General de Agudos Eva Perón, 1650 San Martin, Buenos Aires, Argentina; and.
Bruno LococoHospital Interzonal General de Agudos Eva Perón, 1650 San Martin, Buenos Aires, Argentina; and.
Rick L TarletonCenter for Tropical and Emerging Global Diseases, Athens, GA 30602.
Susana A LaucellaInstituto Nacional de Parasitología Dr. M. Fatala Chaben, Buenos Aires 1063, Argentina; Hospital Interzonal General de Agudos Eva Perón, 1650 San Martin, Buenos Aires, Argentina; and slaucella@yahoo.com.
Administración Nacional de Laboratorios e Institutos de Salud · ARHospital General de Agudos Dr. TEODORO ALVAREZ · ARNational University of General San Martín · ARHospital for Tropical Diseases · VNInstitute of Parasitology · CZ

Funding

VACCINE DISCOVERY FOR TRYPANOSOMA CRUZIP01AI044979 · NIAID · UNIVERSITY OF GEORGIA (UGA) · PI TARLETON, RICK L · 1999 to 2008
$7.5M
NIAID NIH HHS P01 AI044979
6 · The paper itself

Abstract

We have previously demonstrated that immune responses in subjects with chronic Trypanosoma cruzi infection display features common to other persistent infections with signs of T cell exhaustion. Alterations in cytokine receptor signal transduction have emerged as one of the cell-intrinsic mechanisms of T cell exhaustion. In this study, we performed an analysis of the expression of IL-7R components (CD127 and CD132) on CD4(+) and CD8(+) T cells and evaluated IL-7-dependent signaling events in patients at different clinical stages of chronic chagasic heart disease. Subjects with no signs of cardiac disease showed a decrease in CD127(+)CD132(+) cells and a reciprocal gain of CD127(-)CD132(+) in CD8(+) and CD4(+) T cells compared with either patients exhibiting heart enlargement or uninfected controls. T. cruzi infection, in vitro, was able to stimulate the downregulation of CD127 and the upregulation of CD132 on T cells. IL-7-induced phosphorylation of STAT5 as well as Bcl-2 and CD25 expression were lower in T. cruzi-infected subjects compared with uninfected controls. The serum levels of IL-7 were also increased in chronic chagasic patients. The present study highlights perturbed IL-7/IL-7R T cell signaling through STAT5 as a potential mechanism of T cell exhaustion in chronic T. cruzi infection.

Indexed as

AdultAgedCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesChagas DiseaseChronic DiseaseFemaleHumansInterleukin-7Interleukin-7 Receptor alpha SubunitInterleukin Receptor Common gamma SubunitMaleMiddle AgedProto-Oncogene Proteins c-bcl-2Receptors, Interleukin-7Signal TransductionBCL2 protein, humanIL2RG protein, humanIL7 protein, humanInterleukin-7Interleukin-7 Receptor alpha SubunitInterleukin Receptor Common gamma SubunitProto-Oncogene Proteins c-bcl-2Receptors, Interleukin-7STAT5 Transcription Factor

Identifiers

PMID25769928
PMCPMC4391971
OpenAlexW1939965638

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.